Addressing disparities and challenges in underserved patient populations with metastatic breast cancer in Europe
Eduard Vrdoljak,
Joseph Gligorov,
Lieve Wierinck,
PierFranco Conte,
Jacques De Grève,
Françoise Meunier,
Carlo Palmieri,
Luzia Travado,
Andrew Walker,
Theresa Wiseman,
Rachel Wuerstlein,
Emilio Alba,
Concepción Biurrún,
Rosanna D’Antona,
Oriol Sola-Morales,
Catherine Ubaysi,
Roberta Ventura,
Fatima Cardoso
Affiliations
Eduard Vrdoljak
Department of Oncology, University Hospital Center Split, School of Medicine, University of Split, Spinčićeva 1, Split, HR-21.000, Croatia
Joseph Gligorov
Medical Oncology Department, APHP Tenon, 4 Rue de La Chine, Paris, 75020, France
Lieve Wierinck
Brussels, Belgium
PierFranco Conte
Department of Surgery, Oncology and Gastroenterology, University of Padova and Medical Oncology 2, IOV – Istituto Oncologico Veneto I.R.C.C.S., Via Giustiniani 2, Padova, 35124, Italy
Jacques De Grève
Departments of Genetics and Oncology, Universitair Ziekenhuis (UZ) Brussel, Campus Jette Laarbeeklaan 101, Brussels, 1090, Belgium
Françoise Meunier
Federation of European Academies of Medicine, Rue d’ Egmont 11, Brussels, 1000, Belgium
Carlo Palmieri
The Clatterbridge Cancer Center NHS Foundation Trust, 66 Pembroke Place, Liverpool, L7 8YA, UK; Department of Molecular and Clinical Cancer Medicine, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, UK
Luzia Travado
Champalimaud Clinical Center/Champalimaud Foundation, Av. Brasília, Lisbon, 1400-038, Portugal
Andrew Walker
Salus Alba Limited, 20–23 Woodside Place, Glasgow, G3 7QL, United Kingdom
Theresa Wiseman
The Royal Marsden NHS Foundation Trust, Applied Health Research Department, Fulham Road, London, SW3 6JJ, UK
Rachel Wuerstlein
Breast Center, University Hospital Munich (LMU), CCC Munich, Marchioninistraße 15, Munich, D-81377, Germany
Emilio Alba
University Hospital Virgen de La Victoria, Campus de Teatinos, S/N, Málaga, 29010, Spain
Concepción Biurrún
Federación Española de Cáncer de Mama (FECMA), Carrer de Tusset 32, Barcelona, 08006, Spain
Rosanna D’Antona
Europa Donna Italia, Via Conservatorio 15, Milano, 20122, Italy
Oriol Sola-Morales
Health Innovation Technology Transfer ‘Foundation (FHITT), Aragó 60 Ppal 1a, Barcelona, E-08015, Spain
Catherine Ubaysi
Patients en Réseau, Paris, 75006, France
Roberta Ventura
ABC Global Alliance, C/o Champalimaud Foundation, Av. Brasília, Lisbon, 1400-038, Portugal
Fatima Cardoso
ABC Global Alliance, C/o Champalimaud Foundation, Av. Brasília, Lisbon, 1400-038, Portugal; Breast Unit, Champalimaud Clinical Center/Champalimaud Foundation, Lisbon, Portugal; Corresponding author. Breast Unit, Champalimaud Clinical Center/Champalimaud Foundation, Av. Brasília, Lisbon, 1400-038, Portugal.
People with metastatic breast cancer face many challenges and disparities in obtaining optimal cancer care. These challenges are accentuated in underserved patient populations across Europe, who are less likely to receive quality healthcare for reasons including socioeconomic inequalities, educational or cultural status, or geographic location. While there are many local and national initiatives targeted to address these challenges, there remains a need to reduce disparities and improve access to healthcare to improve outcomes, with a focus on multidisciplinary stakeholder engagement.In October 2019, a range of experts in metastatic breast cancer, including healthcare professionals, patient representatives, policymakers and politicians, met to discuss and prioritize the critical needs of underserved patient populations with metastatic breast cancer in Europe. Six key challenges faced by these communities were identified: the need for amplification of the metastatic breast cancer patient voice, better and wider implementation of high-quality guidelines for metastatic breast cancer, more collaboration between stakeholders, tailored support for patients from different cultural and ethnic backgrounds, improved data sharing, and work-related issues. The Expert Panel then conceived and discussed potential actionable goals to address each key challenge. Their conclusions present a set of interrelated approaches to address the different challenges and could serve as the basis for concerted improvement of the lives of patients with metastatic breast cancer in Europe.